Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).

Por Gergely, P, Ernberg, I, Klein, G, Steinitz, M
Publicado em 1977

EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families.

Por Gratama, J W, Oosterveer, M A, Klein, G, Ernberg, I
Publicado em 1990

Effects of pure interferons on Epstein-Barr virus infection in vitro.

Por Andersson, J P, Andersson, U G, Ernberg, I T, Britton, S F, DeLey, M
Publicado em 1985

Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.

Por Altiok, E, Minarovits, J, Hu, L F, Contreras-Brodin, B, Klein, G, Ernberg, I
Publicado em 1992

Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.

Por Finke, J, Rowe, M, Kallin, B, Ernberg, I, Rosén, A, Dillner, J, Klein, G
Publicado em 1987

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.

Por Gratama, J W, Oosterveer, M A, Zwaan, F E, Lepoutre, J, Klein, G, Ernberg, I
Publicado em 1988

5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.

Por Masucci, M G, Contreras-Salazar, B, Ragnar, E, Falk, K, Minarovits, J, Ernberg, I, Klein, G
Publicado em 1989

Epstein-Barr virus-transformed pro-B cells are prone to illegitimate recombination between the switch region of the mu chain gene and other chromosomes.

Por Altiok, E, Klein, G, Zech, L, Uno, M, Henriksson, B E, Battat, S, Ono, Y, Ernberg, I
Publicado em 1989

Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells.

Por Kallin, B, Dillner, J, Ernberg, I, Ehlin-Henriksson, B, Rosén, A, Henle, W, Henle, G, Klein, G
Publicado em 1986

An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid...

Por Dillner, J, Kallin, B, Alexander, H, Ernberg, I, Uno, M, Ono, Y, Klein, G, Lerner, R A
Publicado em 1986

Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.

Por Hu, L F, Minarovits, J, Cao, S L, Contreras-Salazar, B, Rymo, L, Falk, K, Klein, G, Ernberg, I
Publicado em 1991

A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.

Por Chen, F, Zou, J Z, di Renzo, L, Winberg, G, Hu, L F, Klein, E, Klein, G, Ernberg, I
Publicado em 1995

Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma

Por Birgersdotter, A, Baumforth, K R N, Porwit, A, Sjöberg, J, Wei, W, Björkholm, M, Murray, P G, Ernberg, I
Publicado em 2009

EBV gene expression in an NPC-related tumour.

Por Hitt, M M, Allday, M J, Hara, T, Karran, L, Jones, M D, Busson, P, Tursz, T, Ernberg, I, Griffin, B E
Publicado em 1989

HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure.

Por Dingwall, C, Ernberg, I, Gait, M J, Green, S M, Heaphy, S, Karn, J, Lowe, A D, Singh, M, Skinner, M A
Publicado em 1990

Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.

Por Henle, W, Henle, G, Andersson, J, Ernberg, I, Klein, G, Horwitz, C A, Marklund, G, Rymo, L, Wellinder, C, Straus, S E
Publicado em 1987

Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Por Dingwall, C, Ernberg, I, Gait, M J, Green, S M, Heaphy, S, Karn, J, Lowe, A D, Singh, M, Skinner, M A, Valerio, R
Publicado em 1989